Racial differences in surgeons and hospitals for endometrial cancer treatment
- PMID: 21150796
- PMCID: PMC3332036
- DOI: 10.1097/MLR.0b013e3182019123
Racial differences in surgeons and hospitals for endometrial cancer treatment
Abstract
Purpose: To determine whether (1) black and white women with endometrial cancer were treated by different surgical specialties and in different types of hospitals and (2) differences in specialty and hospital type contributed to racial differences in survival.
Methods: Retrospective cohort study of 12,307 women aged 65 years and older who underwent surgical treatment of endometrial cancer between 1991 and 1999 in the 11 Surveillance Epidemiology and End Results registries.
Results: Black women were more likely to have a gynecologic oncologist to perform their surgery and to be treated at hospitals that were higher volume, larger, teaching, National Cancer Institute centers, urban, and where a greater proportion of the surgeries were performed by a gynecologic oncologist. In unadjusted models, black women were over twice as likely as white women who died because of cancer (hazards ratio [HR]: 2.33), but nearly all of the initial racial difference in survival was explained by differences in cancer stage, and grade as well as age and comorbidities at presentation (adjusted HR: 1.10). Surgical specialty was not associated with survival and, of the hospital characteristics studied, only surgical volume was associated with survival (P < 0.005). Adjusting for hospital characteristics did not change the racial difference in survival (HR: 1.10). Adjustment for the specific hospital where the woman was treated eliminated the association between race and surgeon specialty and slightly widened the residual racial difference in survival (HR: 1.23 vs. 1.10).
Conclusions: In contrast to several studies suggesting that blacks with breast cancer, colon cancer, or cardiovascular disease are treated in hospitals with lower quality indicators, black women diagnosed with endometrial cancer in Surveillance Epidemiology and End Results regions between 1991 and 1999 were more likely to be treated by physicians with advanced training and in high volume, large, urban, teaching hospitals. However, except for a modest association with hospital surgical volume, these provider and hospital characteristics were largely unrelated to survival for women with endometrial cancer. The great majority of the difference in survival was explained by differences in tumor and clinical characteristics at presentation.
Similar articles
-
Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?Med Care. 2009 Jul;47(7):765-73. doi: 10.1097/MLR.0b013e31819e1fe7. Med Care. 2009. PMID: 19536008
-
Clinical characteristics associated with racial disparities in endometrial cancer outcomes: A surveillance, epidemiology and end results analysis.Gynecol Oncol. 2018 Feb;148(2):349-356. doi: 10.1016/j.ygyno.2017.12.021. Epub 2017 Dec 21. Gynecol Oncol. 2018. PMID: 29276059
-
Racial disparities in treatment of high-grade endometrial cancer in the Medicare population.Obstet Gynecol. 2015 Apr;125(4):843-851. doi: 10.1097/AOG.0000000000000605. Obstet Gynecol. 2015. PMID: 25751197
-
Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer.Cancer Control. 2009 Jan;16(1):53-6. doi: 10.1177/107327480901600108. Cancer Control. 2009. PMID: 19078930 Review.
-
Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States.Gynecol Oncol. 2013 Sep;130(3):652-9. doi: 10.1016/j.ygyno.2013.05.020. Epub 2013 May 23. Gynecol Oncol. 2013. PMID: 23707671 Free PMC article. Review.
Cited by
-
Mitigating disparity?: Treatment patterns, survival, and recurrence rates by race, ethnicity, and hospital site across a large urban health system.Gynecol Oncol Rep. 2024 Mar 19;53:101372. doi: 10.1016/j.gore.2024.101372. eCollection 2024 Jun. Gynecol Oncol Rep. 2024. PMID: 38584803 Free PMC article.
-
Healthcare access dimensions and uterine cancer survival: a national cancer database study.Front Oncol. 2023 Oct 5;13:1263371. doi: 10.3389/fonc.2023.1263371. eCollection 2023. Front Oncol. 2023. PMID: 37869101 Free PMC article.
-
Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review.Obstet Gynecol. 2023 Oct 1;142(4):967-977. doi: 10.1097/AOG.0000000000005338. Epub 2023 Sep 7. Obstet Gynecol. 2023. PMID: 37734095 Free PMC article. Review.
-
Disparities in gynecologic cancer incidence, treatment, and survival: a narrative review of outcomes among black and white women in the United States.Int J Gynecol Cancer. 2022 Jul 4;32(7):931-938. doi: 10.1136/ijgc-2022-003476. Int J Gynecol Cancer. 2022. PMID: 35523443 Free PMC article. Review.
-
Disparities and interventions in the timeliness of endometrial cancer diagnosis and treatment in the United States: a scoping review protocol.Syst Rev. 2021 Apr 13;10(1):107. doi: 10.1186/s13643-021-01649-x. Syst Rev. 2021. PMID: 33845907 Free PMC article.
References
-
- The Unequal Burden of Cancer: An Assessment of NIH Research and Programs for Ethnic Minorities and the Medically Underserved. Washington, DC: National Academy Press; 1999. - PubMed
-
- Goss E, Lopez AM, Brown CL, Wollins DS, Brawley OW, Raghavan D. American society of clinical oncology policy statement: disparities in cancer care. J Clin Oncol. 2009;27(17):2881–2885. - PubMed
-
- Medicine lo, ed. Washington DC: The National Academies Press; 2002. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. - PubMed
-
- Schulman KA, Berlin JA, Harless W, et al. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med. 1999;340:618–626. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
